Clinical Trial Update: Ultra-Safe Hormonal Strategy: Transdermal Estradiol Added to Progestins for Endometriosis

View source ↗

Summary

A clinical trial update describes a hormonal strategy for endometriosis that adds transdermal estradiol to progestins in the treatment regimen.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometriosis

Drugs mentioned

• Progestin (Progestin)
• Transdermal Estradiol (estradiol)

Snippet

Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Conditions: Endometriosis | Status: ACTIVE_NOT_RECRUITING